Medpharm Limited

Research and experimental development on biotechnology · Guildford

ActiveUnited KingdomIncorporated 1999Private Limited Company

Financial position

Accounts to 2024-12-31 · GBP · Company accounts

Net assets

−£32,500,104

Cash

£216,669

Turnover

£9,041,550

Profit / loss

−£26,200,365

Current assets

£6,652,027

Creditors < 1 year

£41,456,252

Equity

−£32,500,104

Average employees

GBP · company

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

5 periods

Reported figures	2024-12-31Company	2023-12-31Company	2023-01-01Company	2022-12-31Company	2022-01-01Company
Balance sheet
Net assets	−£32,500,104	−£6,292,978	£609,315	£609,315	£5,962,935
Equity	−£32,500,104	−£6,292,978	£609,315	£609,315	£5,962,935
Assets
Fixed assets	£2,304,121	£2,952,924	—	£3,206,847	—
Property, plant & equipment	£2,304,120	£2,786,146	—	£3,040,069	—
Current assets	£6,652,027	£4,663,924	—	£6,980,849	—
Cash at bank	£216,669	£575,269	—	£976,583	—
Stock	—	£50,281	—	£60,642	—
Liabilities
Creditors within one year	£41,456,252	£13,909,826	—	£9,578,381	—
Net current assets	−£34,804,225	−£9,245,902	—	−£2,597,532	—
Assets less current liabilities	−£32,500,104	−£6,292,978	—	—	—
Profit & loss
Turnover	£9,041,550	£11,296,451	—	£18,676,309	—
Gross profit	−£836,938	−£1,859,255	—	£1,062,817	—
Operating profit	−£5,138,759	−£6,946,293	—	−£5,356,901	—
Profit before tax	−£26,052,835	−£6,940,548	—	−£5,355,631	—
Profit / loss	−£26,200,365	−£6,865,187	—	−£4,936,490	—
People
Average employees	78	94	—	115	—
Source evidence	View filing	View filing	View filing	View filing	View filing